Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

November 17, 2026 Ram Iyer

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

Previous Article
Voyage Labs raises $12 million for a specialized AI travel assistant
Voyage Labs raises $12 million for a specialized AI travel assistant

Voyage Labs’ flagship product is called Atlas, meant to work as a personal assistant for your trip-planning...

Next Article
Science Corporation’s brain tech is worth $3.5 billion after new funding
Science Corporation’s brain tech is worth $3.5 billion after new funding

Science Corp raised a $400 million Series D to scale up its anti-blindness business.

LINK CTA

Learn More